The news that production of AZEDRA, the only FDA-approved treatment for metastatic pheo para, will stop in spring 2024 has left us all with many questions. Dr. Dan Pryma and Dr. Erik Mittra will join us to answer some of them in this important informational webinar. You won’t want to miss this one — register now to submit your questions and receive the link to join!
Special Informational Webinar — After AZEDRA: Moving Forward Together
October 12, 2023